Genix Pharmaceuticals Corporation (TSXV:GENX)

Genix Pharmaceuticals Ratios and Metrics

Market cap in millions CAD. Fiscal year is November - October.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 27, 2026	Oct 31, 2025	Oct 31, 2024	Oct 31, 2023	Oct 31, 2022	Oct 31, 2021
Market Cap	1	2	3	2	4	9
Market Cap Growth	-90.00%	-40.00%	25.00%	-42.86%	-53.33%	-11.77%
Enterprise Value	1.98	1.73	2.95	2.36	4.14	8.76
Last Close Price	0.02	0.03	0.05	0.04	0.07	0.15
PS Ratio	-	-	730.98	191.87	-	-
PB Ratio	-0.62	-1.25	-2.50	-2.08	1.30	2.21
P/TBV Ratio	-0.84	-1.26	-2.50	-2.08	1.30	2.21
EV/Sales Ratio	-	-	728.15	190.92	-	-
Debt / Equity Ratio	-	0	0	0	0	0.00
Net Debt / Equity Ratio	-0.70	-0.70	-0.68	-0.44	0.05	-0.02
Net Debt / EBITDA Ratio	-6.39	-6.39	-3.29	-1.49	-0.37	0.08
Net Debt / FCF Ratio	-8.05	-8.05	-4.29	-2.26	-0.79	0.21
Asset Turnover	-	0	0.03	0.05	0	0
Inventory Turnover	-	-	0.03	0.05	0	0
Quick Ratio	0.03	0.03	0.01	0.01	0.02	0.19
Current Ratio	0.03	0.03	0.03	0.16	0.23	0.25
Return on Equity (ROE)	12.11%	12.11%	21.16%	-85.75%	-28.69%	-37.39%
Return on Assets (ROA)	-351.06%	-351.06%	-193.10%	-387.78%	-482.98%	-366.93%
Return on Invested Capital (ROIC)	99.39%	99.39%	236.81%	2561.21%	-112913.00%	2953.22%
Return on Capital Employed (ROCE)	12.08%	12.08%	21.03%	90.26%	151.13%	1742.32%
Buyback Yield / Dilution	-1.38%	-0.54%	0.00%	0.00%	0.00%	-18.55%
Total Shareholder Return	-1.38%	-0.54%	0.00%	0.00%	0.00%	-18.55%

Updated Feb 25, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.